Lynn Seely, Myovant CEO (Myovant)
Myovant readies NDA #3 as relugolix sails to its 5th positive PhIII — this time in endometriosis
Myovant $MYOV is on a roll.
In the last few days the biotech spawned on Vivek Ramaswamy’s Roivant platform has posted a positive readout …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
